Naoko Takebe to Carcinoma, Renal Cell
This is a "connection" page, showing publications Naoko Takebe has written about Carcinoma, Renal Cell.
Connection Strength
0.255
-
Rethinking Oncologic Treatment Strategies with Interleukin-2. Cells. 2023 05 05; 12(9).
Score: 0.201
-
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801.
Score: 0.054